Paper Details

  1. Home
  2. Paper Details

Update on antiplatelet agents, including MATCH, CHARISMA, and ESPRIT.

Author: JamiesonDara G, SkliutMaryna

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Aspirin plus extended-release dipyridamole is effective in preventing recurrent ischemic stroke, while clopidogrel plus aspirin is not.
Paper Details　
Original Abstract of the Article :
Despite recent advances in the acute treatment of stroke, prevention and risk factor modification remain the mainstays of management for patients with ischemic stroke and transient ischemic attack. The majority of noncardioembolic ischemic strokes are atherothrombotic, presumed to be associated with...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11886-008-0004-6

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of Antiplatelet Therapy

The prevention and treatment of ischemic stroke, a medical condition that can leave a person feeling lost in a desert of neurological dysfunction, relies on the use of antiplatelet medications. This review provides an update on the most recent research on antiplatelet agents, including the combination of aspirin and clopidogrel or extended-release dipyridamole. The authors discuss the efficacy and safety of these medications, highlighting the potential benefits and risks associated with their use.

Finding the Right Route

The review emphasizes the importance of individualized treatment plans for stroke prevention and management. While antiplatelet medications have proven effective, the authors highlight the need for careful consideration of patient-specific factors, such as underlying medical conditions, potential drug interactions, and risk of bleeding.

A Journey Through the Landscape of Stroke Prevention

This review provides valuable insights into the ever-evolving landscape of antiplatelet therapy. By carefully considering the information presented, clinicians can make informed decisions that optimize stroke prevention and treatment, guiding their patients toward a safer and healthier future.

Dr. Camel's Conclusion

This review explores the complexities of antiplatelet therapy, highlighting the importance of individualized treatment plans and careful consideration of patient-specific factors. It's like navigating a desert, where choosing the right path can make all the difference. By understanding the potential benefits and risks of each antiplatelet medication, clinicians can provide their patients with the best possible care and support.

Date :
  1. Date Completed 2008-06-03
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18416995

DOI: Digital Object Identifier

10.1007/s11886-008-0004-6

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.